Cleared Traditional

K880217 - SSD-870 CARDIO VASCULAR PHASED ARRAY SE...

K880217 is an FDA 510(k) clearance for SSD-870 CARDIO VASCULAR PHASED ARRAY SE..., manufactured by Ge Medical Systems Information Technologies. The device is a Class 2 Cardiovascular device with product code DXK cleared through the Traditional 510(k) pathway after a 96-day FDA review.

K880217 · Ge Medical Systems Information Technologies · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 1988
Decision
96d
Days
Class 2
Risk

K880217 is an FDA 510(k) clearance for the SSD-870 CARDIO VASCULAR PHASED ARRAY SECTOR SCANN.. Classified as Echocardiograph (product code DXK), Class II - Special Controls.

Submitted by Ge Medical Systems Information Technologies (Wallingford, US). The FDA issued a Cleared decision on April 25, 1988 after a review of 96 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2330 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Ge Medical Systems Information Technologies devices

FDA 510(k) Submission Details - K880217

510(k) Number K880217 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 20, 1988
Decision Date April 25, 1988
Days to Decision 96 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
29d faster than avg
Panel avg: 125d · This submission: 96d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DXK Device Classification - Class 2, Special Controls

Product Code DXK Echocardiograph
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2330
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXK Echocardiograph

All 40
Devices cleared under the same product code (DXK) and FDA review panel - the closest regulatory comparables to K880217.
ULTRAMARK 7 ULTRASOUND SYSTEM
K896543 · Advanced Technology Laboratories, Inc. · Feb 1990
GENESIS III, (MOD. 7003/7004)
K894370 · Biosound, Inc. · Jan 1990
MODEL SSH-140A ULTRASOUND IMAGING SYSTEM
K894632 · Toshiba America Medical Systems, In.C · Oct 1989
EUB-305 DIAGNOSTIC ULTRASOUND DEVICE
K870878 · Hitachi Medical Corp. of America · Apr 1988
RT5000 W/QUANTI. SPEC. DOPPLER, CW DOPP. MODIFICA.
K871555 · General Electric Co. · Mar 1988
GENESIS II, 2.5/5.0 MHZ S.E/5.0MHZ/3.5 16/19 MM AN
K873032 · Biosound, Inc. · Feb 1988